inclusion criteria: * patients with laboratory-confirmed (pcr) covid-19 infection * patients with moderate to severe covid-19 infection * hospitalized patients on clinical centers and cantonal hospitals * patients with radiology-confirmed pneumonia within the clinical condition of covid-19 infection including pulmonary opacity * patients with a clinical indication for pneumonia: increased body temperature (defined as a value above ≥ 36.6⁰c axillary route, ≥ 37.2°c oral route or ≥ 37.8 °c rectal route), and/or dyspnea, and/or cough, and/or spo2 \<96% * patients aged above 18, both genders * patients able and willing to understand the study, adhere to all study procedures and sign a written informed consent form (icf) prior to entering the study or with the assistance of the witness

inclusion criteria: * patients with laboratory-confirmed (pcr) covid-19 infection * patients with moderate to severe covid-19 infection * hospitalized patients on clinical centers and cantonal hospitals * patients with radiology-confirmed pneumonia within the clinical condition of covid-19 infection including pulmonary opacity * patients with a clinical indication for pneumonia: increased body temperature (defined as a value above ≥ 36.6⁰c axillary route, ≥ 37.2°c oral route or ≥ 37.8 °c rectal route), and/or dyspnea, and/or cough, and/or spo2 \<96% * patients aged above 18, both genders * patients able and willing to understand the study, adhere to all study procedures and sign a written informed consent form (icf) prior to entering the study or with the assistance of the witness

inclusion criteria: - patients with laboratory-confirmed (pcr) covid-19 infection - patients with moderate to severe covid-19 infection - hospitalized patients on clinical centers and cantonal hospitals - patients with radiology-confirmed pneumonia within the clinical condition of covid-19 infection including pulmonary opacity - patients with a clinical indication for pneumonia: increased body temperature (defined as a value above ≥ 36.6⁰c axillary route, ≥ 37.2°c oral route or ≥ 37.8 °c rectal route), and/or dyspnea, and/or cough, and/or spo2 <96% - patients aged above 18, both genders - patients able and willing to understand the study, adhere to all study procedures and sign a written informed consent form (icf) prior to entering the study or with the assistance of the witness

inclusion criteria: - patients with laboratory-confirmed (pcr) covid-19 infection - patients with moderate to severe covid-19 infection - hospitalized patients on clinical centers and cantonal hospitals - patients with radiology-confirmed pneumonia within the clinical condition of covid-19 infection including pulmonary opacity - patients with a clinical indication for pneumonia: increased body temperature (defined as a value above ≥ 36.6⁰c axillary route, ≥ 37.2°c oral route or ≥ 37.8 °c rectal route), and/or dyspnea, and/or cough, and/or spo2 <96% - patients aged above 18, both genders - patients able and willing to understand the study, adhere to all study procedures and sign a written informed consent form (icf) prior to entering the study or with the assistance of the witness

inclusion criteria: - patients with laboratory-confirmed (pcr) covid-19 infection - patients with moderate to severe covid-19 infection - hospitalized patients on clinical centers and cantonal hospitals - patients with radiology-confirmed pneumonia within the clinical condition of covid-19 infection including pulmonary opacity - patients with a clinical indication for pneumonia: increased body temperature (defined as a value above ≥ 36.6⁰c axillary route, ≥ 37.2°c oral route or ≥ 37.8 °c rectal route), dyspnea, cough and spo2 <96% - patients aged above 18, both genders - patients able and willing to understand the study, adhere to all study procedures and sign a written informed consent form (icf) prior to entering the study or with the assistance of the witness

inclusion criteria: - patients with laboratory-confirmed (pcr) covid-19 infection - patients with moderate to severe covid-19 infection - hospitalized patients on clinical centers and cantonal hospitals - patients with radiology-confirmed pneumonia within the clinical condition of covid-19 infection including pulmonary opacity - patients with a clinical indication for pneumonia: increased body temperature (defined as a value above ≥ 36.6⁰c axillary route, ≥ 37.2°c oral route or ≥ 37.8 °c rectal route), dyspnea, cough and spo2 <96% - patients aged above 18, both genders - patients able and willing to understand the study, adhere to all study procedures and sign a written informed consent form (icf) prior to entering the study or with the assistance of the witness